Plasmid synthesis services: specifying the construct and the dna vector, what a plasmid dna vector order settles that a plasmid purchase does not, and where plasmid production services, vector production and plasmid dna production at scale become a different purchase

Specifying the order

1. Sequence difficulty drives the price. High GC content, long repeats, homopolymer runs and strong secondary structure all push a construct into a higher difficulty tier and a higher per-base rate. Providers will assess a sequence before quoting, and a construct flagged as difficult is a warning about turnaround as much as about cost.
2. Vector choice is the other half. Delivery in the provider's standard vector is cheapest; a specific expression, viral or shuttle vector is a separate line and sometimes requires you to supply it. Decide the vector from the downstream experiment before the order rather than re-cloning afterwards.
3. Codon optimisation is a choice with consequences. Optimising for an expression host usually raises yield and changes the nucleotide sequence, which matters if the sequence itself is the subject or if regulatory elements sit inside the coding region. Say explicitly whether you want the native sequence or an optimised one.
4. Verification and what you receive. Expect full sequence verification of the delivered construct with the trace, a map, and the plasmid at a stated quantity and purity. A construct delivered without a verified sequence is a construct you will verify yourself before trusting.
5. Quantity, and the format it arrives in. Research orders arrive as a small quantity of dried or suspended DNA suitable for transformation. If you need working quantities immediately, specify the amount and the purity grade, since transfection-grade and endotoxin-limited material are separate specifications.

Where production replaces synthesis

Synthesis gives you the construct once. Producing milligrams or grams of it for transfection, viral vector packaging or a regulated process is a fermentation and purification job with its own specifications: endotoxin limits, supercoiled fraction, residual host protein and RNA, and a defined cell bank behind it.

That is a different supplier conversation and frequently a different supplier. Ordering synthesis and assuming production is a scale-up of the same order is the most common misunderstanding in this category.

Sequence and biosecurity

Synthesis providers screen ordered sequences against sequences of concern, and orders may be queried or refused on that basis. Research involving recombinant nucleic acids also sits under institutional review, and that approval is the ordering laboratory's responsibility rather than the provider's.

Keep the order record with the construct. Provenance of a synthetic construct is asked about more often than it used to be, and reconstructing it later is tedious.

Common questions

What does a plasmid synthesis service deliver?

A sequence-verified construct in a specified vector, with the verification trace, a map and a stated quantity and purity. It builds from a sequence rather than from a template, so no source material is needed.

Should I codon optimise?

Usually yes for expression, since it raises yield, and no if the nucleotide sequence itself is the subject or if regulatory elements sit inside the coding region. Say which you want explicitly.

Is plasmid DNA production the same order?

No. Producing working quantities is a fermentation and purification job with its own specifications for endotoxin, supercoiled fraction and residual host material, frequently from a different supplier.

Will a provider refuse a sequence?

Providers screen orders against sequences of concern and may query or decline one. Institutional approval for recombinant nucleic acid work remains the ordering laboratory's responsibility.

Browse by service class

• Compare Gene synthesis on advertised prices